MediWound Ltd.

NasdaqGM:MDWD Lagerbericht

Marktkapitalisierung: US$198.1m

MediWound Management

Management Kriterienprüfungen 1/4

MediWound's CEO is Ofer Gonen, appointed in Jun 2022, has a tenure of 2.42 years. total yearly compensation is $1.13M, comprised of 42.4% salary and 57.6% bonuses, including company stock and options. directly owns 1.04% of the company’s shares, worth $2.06M. The average tenure of the management team and the board of directors is 1.8 years and 2.3 years respectively.

Wichtige Informationen

Ofer Gonen

Geschäftsführender

US$1.1m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts42.4%
Amtszeit als Geschäftsführer2.4yrs
Eigentum des Geschäftsführers1.0%
Durchschnittliche Amtszeit des Managements1.8yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder2.3yrs

Jüngste Management Updates

Recent updates

MediWound Is A Healthy Investment

Oct 29

Market Participants Recognise MediWound Ltd.'s (NASDAQ:MDWD) Revenues Pushing Shares 43% Higher

Jul 23
Market Participants Recognise MediWound Ltd.'s (NASDAQ:MDWD) Revenues Pushing Shares 43% Higher

Analysts Have Made A Financial Statement On MediWound Ltd.'s (NASDAQ:MDWD) First-Quarter Report

Jun 01
Analysts Have Made A Financial Statement On MediWound Ltd.'s (NASDAQ:MDWD) First-Quarter Report

Revenues Tell The Story For MediWound Ltd. (NASDAQ:MDWD) As Its Stock Soars 25%

May 07
Revenues Tell The Story For MediWound Ltd. (NASDAQ:MDWD) As Its Stock Soars 25%

We're Hopeful That MediWound (NASDAQ:MDWD) Will Use Its Cash Wisely

Feb 28
We're Hopeful That MediWound (NASDAQ:MDWD) Will Use Its Cash Wisely

Optimistic Investors Push MediWound Ltd. (NASDAQ:MDWD) Shares Up 26% But Growth Is Lacking

Feb 01
Optimistic Investors Push MediWound Ltd. (NASDAQ:MDWD) Shares Up 26% But Growth Is Lacking

MediWound Ltd.'s (NASDAQ:MDWD) 26% Share Price Surge Not Quite Adding Up

Dec 18
MediWound Ltd.'s (NASDAQ:MDWD) 26% Share Price Surge Not Quite Adding Up

MediWound Ltd. (NASDAQ:MDWD) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected

Sep 29
MediWound Ltd. (NASDAQ:MDWD) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected

MediWound's NexoBrid for thermal burns in children gets EMA review

Sep 20

Need To Know: Analysts Just Made A Substantial Cut To Their MediWound Ltd. (NASDAQ:MDWD) Estimates

Aug 11
Need To Know: Analysts Just Made A Substantial Cut To Their MediWound Ltd. (NASDAQ:MDWD) Estimates

MediWound GAAP EPS of -$0.13 misses by $0.03, revenue of $4.67M misses by $0.61M

Aug 09

MediWound refiling for NexoBrid to treat severe thermal burns gets FDA review

Aug 03

MediWound adds 13% after favorable data for ulcer candidate

Jul 07

MediWound taps Tzvi Palash as COO

Jun 30

Is MediWound (NASDAQ:MDWD) In A Good Position To Deliver On Growth Plans?

Jun 24
Is MediWound (NASDAQ:MDWD) In A Good Position To Deliver On Growth Plans?

Here's Why We're Watching MediWound's (NASDAQ:MDWD) Cash Burn Situation

Dec 07
Here's Why We're Watching MediWound's (NASDAQ:MDWD) Cash Burn Situation

MediWound: Adjusting My Strategy After NexoBrid CRL

Jul 28

MediWound completes enrollment for interim assessment of mid-stage EscharEx study

Jun 09

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Ofer Gonen im Vergleich zu den Einnahmen von MediWound verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Jun 30 2024n/an/a

-US$20m

Mar 31 2024n/an/a

-US$13m

Dec 31 2023US$1mUS$480k

-US$7m

Sep 30 2023n/an/a

-US$12m

Jun 30 2023n/an/a

-US$14m

Mar 31 2023n/an/a

-US$20m

Dec 31 2022US$850kUS$253k

-US$20m

Vergütung im Vergleich zum Markt: Ofer's total compensation ($USD1.13M) is about average for companies of similar size in the US market ($USD1.48M).

Entschädigung vs. Einkommen: Ofer's compensation has increased whilst the company is unprofitable.

Geschäftsführer

Ofer Gonen (51 yo)

2.4yrs

Amtszeit

US$1,133,000

Vergütung

Mr. Ofer Gonen, B.Sc. MA Economic & Finance, serves as Chief Executive Officer at MediWound Ltd. since June 30, 2022. He was Chief Executive Officer of Clal Biotechnology Industries Ltd.from March 7, 2017...

Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Ofer Gonen
Chief Executive Officer2.4yrsUS$1.13m1.04%
$ 2.1m
Hani Luxenburg
Chief Financial Officer1.5yrsUS$244.00kkeine Daten
Yaron Meyer
Executive VP10.9yrsUS$379.00kkeine Daten
Ety Klinger
Chief Research & Development Officer10.5yrsUS$479.00kkeine Daten
Lior Rosenberg
Co-Founder23.8yrsUS$817.00kkeine Daten
Shmulik Hess
COO & Chief Commercial Officerless than a yearkeine Datenkeine Daten
Liron Gal
Executive Director of Manufacturing Science & Technologyless than a yearkeine Datenkeine Daten
Barry Wolfenson
Executive Vice President of Strategy & Corporate Development1.7yrskeine Datenkeine Daten
Robert Snyder
Chief Medical Officer1.8yrskeine Datenkeine Daten

1.8yrs

Durchschnittliche Betriebszugehörigkeit

54yo

Durchschnittliches Alter

Erfahrenes Management: MDWD's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.

Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Stephen Wills
Independent Director7.5yrskeine Datenkeine Daten
Nachum Shamir
Executive Independent Chairman2.3yrskeine Datenkeine Daten
David Fox
Independent Director4.6yrskeine Datenkeine Daten
Vickie Driver
Independent Director7.5yrskeine Datenkeine Daten
Samuel Moed
Member of Strategic Advisory Board2.1yrskeine Datenkeine Daten
Shmuel Rubinstein
Independent Director1.3yrskeine Datenkeine Daten
John Lantis
Member of Strategic Advisory Board2.1yrskeine Datenkeine Daten

2.3yrs

Durchschnittliche Betriebszugehörigkeit

70yo

Durchschnittliches Alter

Erfahrener Vorstand: MDWD's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.